Gaps In Access To Opioid Use Disorder Treatment For Medicare Beneficiaries.

Aged Humans Medicare Medicare Part D Opioid-Related Disorders / drug therapy United States
Drug use FDA approvals process Health conditions Health policy Medicare Medicare Part D Older adults Opioid use disorder Pharmaceuticals Substance abuse access to care

Journal

Health affairs (Project Hope)
ISSN: 1544-5208
Titre abrégé: Health Aff (Millwood)
Pays: United States
ID NLM: 8303128

Informations de publication

Date de publication:
02 2020
Historique:
entrez: 4 2 2020
pubmed: 6 2 2020
medline: 15 5 2021
Statut: ppublish

Résumé

In 2016 only 13.8 percent of substance use disorder treatment programs offered medication treatment for opioid use disorder for older adults who used Medicare to pay for treatment. With increasing demand for treatment among older adults and a rapidly aging population, improved access to medication treatment for this population is needed.

Identifiants

DOI: 10.1377/hlthaff.2019.00309 PMID: 32011945
pubmed: 32011945
doi: 10.1377/hlthaff.2019.00309
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

233-237

Auteurs

Samantha J Harris (SJ)

Samantha J. Harris ( sjh75852@uga. edu ) is a doctoral candidate in the Department of Public Administration and Policy, University of Georgia School of Public and International Affairs, in Athens.

Amanda J Abraham (AJ)

Amanda J. Abraham is an associate professor in the Department of Public Administration and Policy, University of Georgia School of Public and International Affairs, in Athens.

Christina M Andrews (CM)

Christina M. Andrews is an associate professor in the College of Social Work, University of South Carolina, in Columbia.

Courtney R Yarbrough (CR)

Courtney R. Yarbrough is an assistant professor in the Department of Health Policy and Management, Rollins School of Public Health, Emory University, in Atlanta, Georgia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Sujet âgé › Gaps In Access To Opioid Use Disorder...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Gaps In Access To Opioid Use Disorder...
questionsmedicales.fr › Organisations et économie des soins de santé › Contrôle social formel › Législation comme sujet › Medicare (USA) › Gaps In Access To Opioid Use Disorder...
questionsmedicales.fr › Organisations et économie des soins de santé › Contrôle social formel › Législation comme sujet › Medicare part D (USA) › Gaps In Access To Opioid Use Disorder...
questionsmedicales.fr › Troubles mentaux › Troubles liés à une substance › Troubles liés à l'usage de substances psychotropes › Troubles liés aux opiacés › Gaps In Access To Opioid Use Disorder...
questionsmedicales.fr › Régions géographiques › Amériques › Amérique du Nord › États-Unis › Gaps In Access To Opioid Use Disorder...